StockData

Tanke Biosciences Corp (TNBI) stock

TNBIOTCGrain Mill ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2013, quý kết thúc ngày Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $399.72KP/E –Yield –

Tanke Biosciences Corp saw revenue fall 19.5% to $22.96M over the twelve months to Sep 30, 2013. Operating income fell 101.1% to -$57.27K, moving the operating margin from 18.2% to -0.2%. Free cash flow was -$6.13M, down 273.3% from a year earlier. At the latest close the market valued the company at $399.72K.

Revenue
$22.96M
-19.5% vs. a year earlier
Operating income
-$57.27K
-101.1% vs. a year earlier
Free cash flow
-$6.13M
-273.3% vs. a year earlier
EPS, diluted
-$0.12
-163.2% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2013

Valuation

Market cap
$399.72K
P/E ratio
–
Price to sales
0.02
Price to book
0.03
Dividend yield
–
Free cash flow yield
-1532.72%

Fundamentals

Revenue
$22.96M
Net income
-$1.64M
EPS, diluted
-$0.12
Free cash flow
-$6.13M
Book value per share
$1.17
Diluted shares
13M

Trading

Previous close
$0.03
Open
$0.03
Day's range
$0.03 – $0.03
Volume
0

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodTNBIS&P 500DifferenceTNBI per yearS&P 500 per year
1 month+200.0%+0.6%+199.4 pts
3 months+50.0%+3.4%+46.6 pts
Year to date+14.1%+13.3%+0.8 pts
1 year-40.0%+16.6%−56.6 pts
3 years-70.0%+86.4%−156.4 pts-33.1%+23.1%
5 years-97.3%+81.9%−179.2 pts-51.6%+12.7%
10 years+50.0%+318.9%−268.9 pts+4.1%+15.4%

Four years at a glance

Fiscal years 2009 to 2012 and trailing twelve months, USD

Revenue

$22.96M-19.5% YoY

Gross profit

$7.41M-26.2% YoY

Operating income

-$57.27K-101.1% YoY

Net income

-$1.64M-164.1% YoY

EPS, diluted

-$0.12-163.2% YoY

Free cash flow

-$6.13M-273.3% YoY
Reported periodTrailing twelve months

About Tanke Biosciences

Grain Mill Products

Tanke Biosciences Corporation develops, manufactures, and supplies animal nutrition products and feed additives. Its primary product lines include organic trace mineral additives, feed acidifiers, flavor enhancers and seasonings, and herbal medicinal additives, as well as water-soluble multi-vitamin electrolytes. These nutritional products are formulated to support the growth and health of livestock, such as swine, poultry, and cattle, in addition to farmed fish and seafood. The company serves major feed manufacturers, large-scale commercial farming operations, and smaller agricultural farms through regional and local distribution partners.

Company profile, executives and history

Tanke Biosciences stock: common questions

What is Tanke Biosciences's stock price?

TNBI closed at $0.03 on Oct 19, 2026, up 0.00% on the day.

What is Tanke Biosciences's market cap?

Tanke Biosciences was worth $399.72K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is TNBI's P/E ratio?

Tanke Biosciences lost money over the twelve months to Sep 30, 2013 (diluted EPS -$0.12), so it has no meaningful P/E ratio.

How much revenue does Tanke Biosciences make?

Tanke Biosciences reported revenue of $22.96M for the twelve months to Sep 30, 2013, down 19.5% from a year earlier.

Does Tanke Biosciences pay a dividend?

No. Tanke Biosciences has not paid a cash dividend over the last twelve months.

How has TNBI stock performed over the past year?

Including dividends, TNBI returned -40.0% over the past year, against +16.6% for the S&P 500.

Who are Tanke Biosciences's competitors?

Companies most similar to Tanke Biosciences by business, industry and size include INGR, FRPT, AFRI, POST, UCFI.

See a number that looks wrong?